Armodafinil Reference

Plain English

What it is

Armodafinil is a prescription wakefulness medicine sold under the brand name Nuvigil. The FDA has approved it to help adults who are too sleepy during the day because of narcolepsy, obstructive sleep apnea, or shift work disorder. It is the R-enantiomer (one of the two mirror-image halves) of the drug modafinil, and it tends to stay active in the body longer.

What people use it for

On its label it is used to cut down excessive daytime sleepiness tied to those sleep conditions. Outside the label, some people in the nootropic community use it to stay focused and push through fatigue, often those who feel modafinil fades too early. That brain-boosting use is off-label and falls outside what the FDA approved.

What the science shows

As an FDA-approved drug, armodafinil has solid human evidence that it improves wakefulness in the sleep disorders listed on its label. Its value as a general focus or memory booster in otherwise healthy people is far weaker and not well established.

The catch

Armodafinil is a Schedule IV controlled substance and is prescription-only, so having it without a prescription is a federal offense. The label warns about rare but serious, even life-threatening skin reactions, including Stevens-Johnson syndrome. It also carries a real risk of abuse and misuse.

Reference summary

Armodafinil is the R-enantiomer of modafinil with a longer half-life. Label-verified for the same sleep-medicine indications.

Regulatory and posture

Categories

Nootropic

Aliases

Nuvigil, R-modafinil enantiomer

Evidence posture

human - FDA-approved Schedule IV controlled substance. Off-label cognitive-enhancement use is outside the approved indication. Possession without a prescription is a federal offense.

Regulatory status

FDA-approved prescription medication (Nuvigil). Same indications as modafinil. Schedule IV controlled substance.

Content review status

label verified